Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

- PMLiVE

The biosimilars are coming

Lilly on navigating the regulatory pathway for its insulin glargine

- PMLiVE

Novartis brings creative malaria campaign to Pinterest

Invites users to create their own mosquito-killing story

- PMLiVE

NICE set to back Alexion’s costly ‘ultra-orphan’ drug

Final draft guidance recommends aHUS treatment Soliris

- PMLiVE

New European health comms network launches

Founding members of HEAL include the UK’s Packer Forbes and CGC of Germany

- PMLiVE

First trial results positive for GSK Ebola vaccine

ChAd3-EBO is safe and able to stimulate response

- PMLiVE

BMS’ daclatasvir scuppered by decision to drop companion drug

FDA denies approval due to discontinuation of asunaprevir development

- PMLiVE

Sanofi nominates Bonnie Bassler to board

She has over 20 years of experience

- PMLiVE

Novo Nordisk’s chief of staffs to leave

Company reduces number of executives from seven to six

- PMLiVE

NICE backs drug to cut alcohol consumption

Final guidance for Lundbeck’s Selincro for use on NHS in England

Monitoring the social media activity of HCPs

Do your research when planning a digital engagement strategy

- PMLiVE

FDA adds rare brain infection link to Tecfidera labelling

Biogen Idec’s MS drug gets safety warning

- PMLiVE

Amgen/AZ confirm brodalumab psoriasis filing in 2015

Drug demonstrates greater effectiveness than J&J’s Stelara

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links